Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Flawed EPA Analysis Rejects Finding That Glyphosate Is a Probable Carcinogen

WASHINGTON -

The U.S. Environmental Protection Agency today released controversial analyses that rely heavily on industry studies to conclude that glyphosate poses no significant risks to humans.

The EPA review, which ignored the agency’s own guidelines for assessing cancer risks, contradicts a 2015 World Health Organization analysis of published research that determined glyphosate is a probable carcinogen.

Glyphosate is the active ingredient in Monsanto’s Roundup and most widely used pesticide in the world; 300 million pounds of it are used in the U.S. each year.

“The only way the EPA could conclude that glyphosate poses no significant risks to human health was to analyze industry studies and ignore its own guidelines when estimating cancer risk,” said Nathan Donley, a senior scientist at the Center for Biological Diversity. “The EPA’s biased assessment falls short of the most basic standards of independent research and fails to give Americans an accurate picture of the risks posed by glyphosate use.”

A federal advisory panel of independent scientists unanimously found earlier this year that in assessing glyphosate the pesticides office at the EPA failed to follow its own guidelines for determining whether a chemical can cause cancer. In the final draft released today, the EPA stated that the guidelines “... are intended as a guidance only …” and do not necessarily have to be followed.

Scientists typically use previously agreed upon guidelines to prevent biases from swaying the analysis in one direction or another.

The chair of the EPA's Cancer Assessment Review Committee, Jess Rowland, resigned in 2015 amid controversy. Emails obtained in litigation brought against Monsanto by cancer victims and their families uncovered a disturbingly cozy relationship between the EPA and Monsanto on matters involving the glyphosate risk assessment.

In one example, when the U.S. Department of Health and Human Services announced that it would be reviewing glyphosate’s safety, Rowland assured Monsanto officials he would work to thwart the review, saying, “If I can kill this, I should get a medal.” The Health and Human Services review was never conducted.

In addition to evaluating the risks of glyphosate to human health, the EPA also analyzed risks to plants and animals and found that serious harms could result from using glyphosate, including that exposure from spray drift could harm the growth and reproduction of birds and mammals. It also found that exposure to small mammals exceeded by 10-fold the agency’s level of concern, the exposure level known to cause harm.

In its analysis of harms to plants and animals, the EPA’s assessment included only four paragraphs on harms to the imperiled monarch butterfly. But it concluded that field buffers up to 600 feet would be needed to prevent harm to milkweed, the sole host plant for monarch caterpillars.

Migratory monarch populations have declined by 80 percent in the past two decades, and their decline has been driven in large part by the surge in glyphosate use resulting from the widespread planting of corn and soybeans crops genetically engineered to tolerate glyphosate. Glyphosate is a potent killer of milkweed. The dramatic surge in the glyphosate use has virtually wiped out milkweed plants in the Midwest's corn and soybean fields.

There are currently no field buffers in place to protect milkweed and monarchs from glyphosate.

Monarch butterfly

Monarch butterfly photo by John Buse, Center for Biological Diversity.

###

At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature — to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law and creative media, with a focus on protecting the lands, waters and climate that species need to survive. 

160 Patient Advocates Demand Medicare Negotiation in Build Back Better Package

"We're confident that inclusion of comprehensive drug pricing reforms in the reconciliation package will lower prices, save lives, and ensure continued development of innovative new drugs."

Jessica Corbett ·


'Cartoonish Level Corrupt': As Dems Fight for Bold Agenda, Sinema to Fundraise With Its Corporate Opponents

"Sinema is setting her political future on fire," said one Democratic organizer. "If she doesn't change course drastically and soon, it will be too late."

Brett Wilkins ·


'Momentous Win': Years of Local Opposition Defeats PennEast Pipeline

Opponents in Pennsylvania and New Jersey cheer "cancellation of this unneeded, dangerous fracked gas pipeline."

Jessica Corbett ·


Amid Calls for Closure, House Dems Urge NYC Officials to End 'Inhumane Conditions' at Rikers

A dozen prisoners have died this year alone at the notoriously violent and overcrowded jail complex.

Brett Wilkins ·


'Quite Literally What Instigated the Tunisian Revolution': Outrage After NYC Food Vendor's Stall 'Trashed'

"The abuse of street vendors will continue until there is legislative change, creating a pathway for New York City's smallest businesses to formalize."

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo